7-OH Federal Ban: What California Families Should Know

A note from the clinical team

7-OH has been sold beside the energy drinks as if it were something gentle. Federal regulators are about to treat it as what it acts like in the body. For anyone who takes it daily, the weeks around that change deserve a plan.

MY LIMITLESS JOURNEYS  /  SERVING SOUTHERN CALIFORNIA FROM ENCINO

Is 7-OH about to be banned?

Federally, it is close. On October 14, 2026, the Drug Enforcement Administration published a notice of intent to temporarily place 7-hydroxymitragynine (7-OH) in Schedule I when products contain it above a set threshold, and a temporary order can be published on or after November 13. California health officials have already told retailers these products are not approved for sale. Anyone who uses 7-OH daily should talk with a clinician before supply runs out, because stopping suddenly can bring on opioid withdrawal.

What is 7-OH, and how is it different from kratom?

Kratom is a tree native to Southeast Asia whose leaves contain dozens of active compounds. One of them, 7-hydroxymitragynine, makes up less than 2 percent of the alkaloids in the natural leaf, according to the FDA. The products now sold as “7-OH” are different. They concentrate that one compound, often semi-synthetically, into tablets, shots and gummies sold in smoke shops, gas stations and online.

The distinction matters clinically. The FDA describes 7-OH as having substantially greater activity at the mu-opioid receptor than mitragynine, kratom’s main compound, and than classical opioids such as morphine. When the agency recommended scheduling in July 2025, it was specific: the target was concentrated 7-OH, not natural kratom leaf. The FDA lists physical dependence, withdrawal and respiratory depression among the risks.

Most people who use 7-OH do not think of it as an opioid. It is often bought to get through a shift, ease back pain, take the edge off anxiety or step down from another drug. That framing is exactly why dependence can build quietly.

What did the DEA announce?

On October 14, the DEA published a notice of intent in the Federal Register to temporarily place 7-OH and a related compound, mitragynine pseudoindoxyl, in Schedule I when a product contains either one, or both combined, above a specified threshold. The notice replaces an earlier July proposal, and it adds that neither federal health officials nor the DEA have found these substances safe below that line.

Temporary scheduling requires 30 days’ notice. The companion notice published the same day states that the order will be published on or after November 13, 2026, and takes effect on publication. Three related compounds, mitragynine pseudoindoxyl, MGM-15 and MGM-16, have been in Schedule I under a temporary order since August 26. Schedule I is the most restrictive federal category, reserved for substances with no accepted medical use and a high potential for misuse.

What has California already done?

California moved first. In November 2025, Los Angeles County Public Health tied six overdose deaths to 7-OH products, and ABC7 reported that alcohol was present in every case. On January 16, the California Department of Public Health warned retailers and the public that kratom-derived and 7-OH products are not legally approved for sale for consumption, and said it had seized more than $5 million worth of them with state alcohol and tax regulators.

Some industry and advocacy groups dispute how far that state authority reaches, and products have remained easy to find. That is part of why the federal decision matters: a Schedule I order would remove any doubt about whether these products can be sold at all.

What happens when someone who uses 7-OH every day suddenly can’t get it?

Clinicians watch for two things when a supply changes overnight.

Unplanned withdrawal. Because 7-OH acts on opioid receptors, stopping after regular use can bring on symptoms that look like opioid withdrawal: restlessness, sweating, yawning, muscle aches, stomach cramps, diarrhea, goosebumps and broken sleep. MedlinePlus describes opioid withdrawal as very uncomfortable but usually not life threatening, though vomiting and diarrhea can lead to dehydration. The discomfort is also what pulls many people back toward using. CDPH also lists anxiety, insomnia and seizures among the risks tied to these products.

A switch to something stronger. Someone in withdrawal who cannot find 7-OH may reach for pills or powder from another source. In Los Angeles, that supply is dominated by fentanyl and now includes newer synthetic opioids that test strips can miss. Pills that look pharmaceutical are often counterfeit. A person whose tolerance was built on 7-OH has no reliable way to judge a dose of either.

How is 7-OH dependence treated?

There is no FDA-approved medication made specifically for kratom or 7-OH dependence. The National Institute on Drug Abuse notes that researchers have used medications in a limited number of cases and that larger clinical trials are still needed. FDA-approved medications do exist for opioid use disorder, and because 7-OH acts on the same receptors, a physician may consider them case by case.

In practice, a good assessment starts with three questions: how much and how often, what else is being used (alcohol especially, given the Los Angeles deaths), and what happened during any earlier attempt to stop. From there, withdrawal can be managed with monitoring, comfort medications and, when appropriate, opioid treatment medications, in a setting matched to the risk. Our pages on opioid and fentanyl detox and detox medications explain what that looks like, and medical detox versus quitting at home covers how to decide.

“7-OH is sold as something gentler than what it is. Families tend to learn what they are dealing with in the first days without it. We would much rather have that conversation before those days arrive.”

Garrett Braukman, Executive Director, SoCal West Region, Emend Healthcare

What can families do this week?

Ask about the product, not the person. “I read that the shots you take are about to be banned. Have you thought about what happens if you can’t get them?” lands better than a question about addiction. Our guide to talking with a loved one about help has more language that holds.

Keep naloxone in the house. CDPH states that naloxone reverses opioid overdose, including overdose related to 7-OH. It is sold without a prescription at California pharmacies.

Separate it from alcohol. CDPH advises never mixing 7-OH with alcohol or other drugs. Both slow breathing, and together they do it more.

Plan the stop before the shelf decides it. A call with a physician or an addiction treatment team now, while the product is still available, makes a gradual, supervised plan possible. Waiting turns it into an emergency.

Watch for a substitution. New pills, a new contact or money moving in unusual ways in the weeks after November 13 are worth noticing, gently and early.

Where does My Limitless Journeys fit?

My Limitless Journeys is a six-bed residence in Encino, licensed by the California Department of Health Care Services (license 191135CP) and accredited by The Joint Commission. Care begins with on-site medically supervised detox and continues through our residential treatment program and step-down care, with the same clinical team throughout. Our page on opioid addiction treatment explains the approach, and families across Los Angeles and Orange County reach us for detox planning.

If you are unsure whether treatment is needed, a confidential benefits check takes a few minutes and commits you to nothing. SAMHSA’s free and confidential National Helpline, 1-800-662-4357, is another place to start, and Poison Control, 1-800-222-1222, can advise on a suspected exposure.

Frequently asked questions

When does the federal 7-OH ban take effect?

The DEA published its notice of intent on October 14, 2026. Under federal law a temporary scheduling order needs 30 days’ notice, so it can be published on or after November 13, 2026, and takes effect on the day it is published. It applies to products containing 7-OH above a specified threshold.

Is 7-OH the same as kratom?

No. 7-OH is one compound found in small amounts in kratom leaf, less than 2 percent of its alkaloids according to the FDA. Products sold as 7-OH concentrate it, and the FDA says it acts more strongly on opioid receptors than kratom’s main compound or morphine.

What does 7-OH withdrawal feel like?

Because 7-OH acts on opioid receptors, withdrawal after regular use resembles opioid withdrawal: restlessness, sweating, aches, stomach cramps, diarrhea and poor sleep. California health officials also list anxiety and seizures among the risks. A clinician can assess severity and make withdrawal safer and more bearable.

Does naloxone work on a 7-OH overdose?

Yes. The California Department of Public Health states that naloxone can reverse an opioid overdose, including one related to 7-OH. Call 911 as well, because naloxone can wear off before the drug does.

This article is general information, not a diagnosis, legal advice or a substitute for an assessment by a clinician. Regulatory details can change; check the Federal Register for the current status. If someone is in immediate danger, call 911. In a mental health or substance use crisis, call or text 988.

Sources

1. Drug Enforcement Administration. “Schedules of Controlled Substances: Temporary Placement of 7-Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I.” Federal Register, October 14, 2026, document 2026-20943. federalregister.gov
2. Drug Enforcement Administration. “Schedules of Controlled Substances: Temporary Placement of MGM-15 and MGM-16 in Schedule I.” Federal Register, October 14, 2026, document 2026-20942. federalregister.gov
3. Drug Enforcement Administration. “Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I.” Federal Register, August 26, 2026, document 2026-17429. federalregister.gov
4. U.S. Food and Drug Administration. “FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers.” July 29, 2025. fda.gov
5. U.S. Food and Drug Administration. “FDA and Kratom.” Content current as of December 2, 2025. fda.gov
6. California Department of Public Health. “CDPH Warns Retailers and Public About the Dangers of Kratom-derived Products and 7-OH.” News release NR26-005, January 16, 2026. cdph.ca.gov
7. ABC7. “CDPH warns about potentially dangerous substances Kratom and 7-OH after overdose concerns in Los Angeles County.” January 2026. abc7news.com
8. National Institute on Drug Abuse. “Kratom.” nida.nih.gov
9. MedlinePlus Medical Encyclopedia. “Opiate and opioid withdrawal.” U.S. National Library of Medicine. medlineplus.gov
10. SAMHSA, National Helpline, 1-800-662-HELP (4357). samhsa.gov

Every article on this site is written by our editorial team and reviewed by a licensed clinician. Read how we write and review content.

Keep reading: What fentanyl test strips miss · Counterfeit pills and fentanyl · Fentanyl withdrawal and detox · When someone says they can stop on their own